Annual Total Liabilities
$1.21 M
+$804.80 K+199.26%
August 31, 2024
Summary
- As of February 8, 2025, LEXX annual total liabilities is $1.21 million, with the most recent change of +$804.80 thousand (+199.26%) on August 31, 2024.
- During the last 3 years, LEXX annual total liabilities has risen by +$1.01 million (+494.54%).
- LEXX annual total liabilities is now -40.01% below its all-time high of $2.01 million, reached on October 31, 2006.
Performance
LEXX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$399.70 K
-$809.00 K-66.93%
November 30, 2024
Summary
- As of February 8, 2025, LEXX quarterly total liabilities is $399.70 thousand, with the most recent change of -$809.00 thousand (-66.93%) on November 30, 2024.
- Over the past year, LEXX quarterly total liabilities has stayed the same.
- LEXX quarterly total liabilities is now -80.16% below its all-time high of $2.01 million, reached on October 31, 2006.
Performance
LEXX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LEXX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +199.3% | 0.0% |
| 3 y3 years | +494.5% | +42.0% |
| 5 y5 years | +555.1% | +42.0% |
LEXX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +500.1% | -66.9% | +105.4% |
| 5 y | 5-year | at high | +555.1% | -66.9% | +531.4% |
| alltime | all time | -40.0% | >+9999.0% | -80.2% | +1830.9% |
Lexaria Bioscience Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $399.70 K(-66.9%) |
| Aug 2024 | $1.21 M(+199.3%) | $1.21 M(+345.4%) |
| May 2024 | - | $271.40 K(+32.9%) |
| Feb 2024 | - | $204.20 K(-19.6%) |
| Nov 2023 | - | $254.00 K(-37.1%) |
| Aug 2023 | $403.90 K(+100.5%) | $403.90 K(-66.3%) |
| May 2023 | - | $1.20 M(+437.2%) |
| Feb 2023 | - | $223.10 K(-20.7%) |
| Nov 2022 | - | $281.50 K(+39.8%) |
| Aug 2022 | $201.40 K(-0.9%) | $201.40 K(-10.6%) |
| May 2022 | - | $225.20 K(+15.7%) |
| Feb 2022 | - | $194.60 K(-29.8%) |
| Nov 2021 | - | $277.30 K(+36.4%) |
| Aug 2021 | $203.30 K(-41.2%) | $203.30 K(-27.8%) |
| May 2021 | - | $281.40 K(-40.1%) |
| Feb 2021 | - | $469.50 K(+32.9%) |
| Nov 2020 | - | $353.30 K(+2.1%) |
| Aug 2020 | $346.00 K(+87.5%) | $346.00 K(+189.1%) |
| May 2020 | - | $119.70 K(+89.1%) |
| Feb 2020 | - | $63.30 K(-51.4%) |
| Nov 2019 | - | $130.20 K(-29.4%) |
| Aug 2019 | $184.50 K(+323.2%) | $184.50 K(+39.5%) |
| May 2019 | - | $132.30 K(-73.5%) |
| Feb 2019 | - | $500.10 K(+285.0%) |
| Nov 2018 | - | $129.90 K(+197.9%) |
| Aug 2018 | $43.60 K(-52.8%) | $43.60 K(-39.1%) |
| May 2018 | - | $71.60 K(+3.8%) |
| Feb 2018 | - | $69.00 K(-27.9%) |
| Nov 2017 | - | $95.70 K(+3.7%) |
| Aug 2017 | $92.30 K(-80.7%) | $92.30 K(+8.6%) |
| May 2017 | - | $85.00 K(-77.5%) |
| Feb 2017 | - | $378.50 K(-26.3%) |
| Nov 2016 | - | $513.50 K(+7.2%) |
| Aug 2016 | $478.90 K(+769.1%) | $478.90 K(+27.2%) |
| May 2016 | - | $376.50 K(+32.4%) |
| Feb 2016 | - | $284.30 K(+60.3%) |
| Nov 2015 | - | $177.40 K(+222.0%) |
| Aug 2015 | $55.10 K | $55.10 K(-12.0%) |
| May 2015 | - | $62.60 K(+64.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $38.10 K(-95.2%) |
| Nov 2014 | - | $789.40 K(-22.4%) |
| Aug 2014 | $918.00 K(-37.7%) | - |
| Jul 2014 | - | $1.02 M(-8.0%) |
| Apr 2014 | - | $1.10 M(-27.9%) |
| Jan 2014 | - | $1.53 M(+3.9%) |
| Oct 2013 | $1.47 M(-16.7%) | $1.47 M(+1.1%) |
| Jul 2013 | - | $1.46 M(-5.2%) |
| Apr 2013 | - | $1.54 M(-4.7%) |
| Jan 2013 | - | $1.61 M(-8.8%) |
| Oct 2012 | $1.77 M(+5.5%) | $1.77 M(-3.6%) |
| Jul 2012 | - | $1.84 M(+1.4%) |
| Apr 2012 | - | $1.81 M(+8.0%) |
| Jan 2012 | - | $1.68 M(-0.1%) |
| Oct 2011 | $1.68 M(+49.2%) | $1.68 M(+13.7%) |
| Jul 2011 | - | $1.48 M(-6.6%) |
| Apr 2011 | - | $1.58 M(-4.2%) |
| Jan 2011 | - | $1.65 M(+46.6%) |
| Oct 2010 | $1.12 M(+9.0%) | $1.12 M(-7.3%) |
| Jul 2010 | - | $1.21 M(+4.1%) |
| Apr 2010 | - | $1.16 M(+9.8%) |
| Jan 2010 | - | $1.06 M(+2.9%) |
| Oct 2009 | $1.03 M(+3.1%) | $1.03 M(+30.9%) |
| Jul 2009 | - | $788.20 K(-3.1%) |
| Apr 2009 | - | $813.30 K(+2.8%) |
| Jan 2009 | - | $790.80 K(-21.0%) |
| Oct 2008 | $1.00 M(+149.6%) | $1.00 M(+29.6%) |
| Jul 2008 | - | $772.30 K(+1.5%) |
| Apr 2008 | - | $760.80 K(-14.1%) |
| Jan 2008 | - | $885.80 K(+120.9%) |
| Oct 2007 | $401.00 K(-80.1%) | $401.00 K(-22.0%) |
| Jul 2007 | - | $514.30 K(+419.0%) |
| Apr 2007 | - | $99.10 K(+378.7%) |
| Jan 2007 | - | $20.70 K(-99.0%) |
| Oct 2006 | $2.01 M(>+9900.0%) | $2.01 M(+8365.1%) |
| Jul 2006 | - | $23.80 K(-16.2%) |
| Apr 2006 | - | $28.40 K(+6.0%) |
| Jan 2006 | - | $26.80 K |
| Oct 2005 | $11.20 K | - |
FAQ
- What is Lexaria Bioscience annual total liabilities?
- What is the all time high annual total liabilities for Lexaria Bioscience?
- What is Lexaria Bioscience annual total liabilities year-on-year change?
- What is Lexaria Bioscience quarterly total liabilities?
- What is the all time high quarterly total liabilities for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly total liabilities year-on-year change?
What is Lexaria Bioscience annual total liabilities?
The current annual total liabilities of LEXX is $1.21 M
What is the all time high annual total liabilities for Lexaria Bioscience?
Lexaria Bioscience all-time high annual total liabilities is $2.01 M
What is Lexaria Bioscience annual total liabilities year-on-year change?
Over the past year, LEXX annual total liabilities has changed by +$804.80 K (+199.26%)
What is Lexaria Bioscience quarterly total liabilities?
The current quarterly total liabilities of LEXX is $399.70 K
What is the all time high quarterly total liabilities for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly total liabilities is $2.01 M
What is Lexaria Bioscience quarterly total liabilities year-on-year change?
Over the past year, LEXX quarterly total liabilities has changed by $0.00 (0.00%)